{"id":67891,"date":"2026-06-10T14:54:48","date_gmt":"2026-06-10T06:54:48","guid":{"rendered":"https:\/\/flcube.com\/?p=67891"},"modified":"2026-06-10T14:54:48","modified_gmt":"2026-06-10T06:54:48","slug":"chinas-national-health-commission-launches-anti-corruption-campaign-targeting-pharmaceutical-sales-and-healthcare-services-misconduct","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=67891","title":{"rendered":"China&#8217;s National Health Commission Launches Anti-Corruption Campaign Targeting Pharmaceutical Sales and Healthcare Services Misconduct"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">China&#8217;s <strong>National Health Commission (NHC)<\/strong> released the <strong>&#8220;Notice on Key Points for Rectifying Misconduct in Pharmaceutical Sales, Procurement, and Healthcare Services&#8221;<\/strong> this week, marking a significant escalation in the government&#8217;s ongoing anti-corruption efforts within the healthcare sector.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The comprehensive directive establishes a <strong>concentrated campaign framework<\/strong> designed to address systemic corruption through <strong>multi-sector collaboration<\/strong>, strengthen <strong>industry self-discipline<\/strong>, and eliminate <strong>risks and hidden dangers<\/strong> in pharmaceutical sales and procurement processes while elevating the standardization of health services nationwide.<\/p>\n\n\n\n<h2 id=\"h-regulatory-framework-amp-key-objectives\" class=\"wp-block-heading\">Regulatory Framework &amp; Key Objectives<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Initiative Component<\/th><th>Scope<\/th><th>Implementation Approach<\/th><\/tr><\/thead><tbody><tr><td><strong>Multi-Sector Collaboration<\/strong><\/td><td>Cross-ministerial coordination<\/td><td>NHC leading with MOFCOM, SAMR, NHSA participation<\/td><\/tr><tr><td><strong>Industry Self-Discipline<\/strong><\/td><td>Pharmaceutical manufacturers, distributors, healthcare providers<\/td><td>Mandatory compliance programs and internal audits<\/td><\/tr><tr><td><strong>Violation Rectification<\/strong><\/td><td>Typical legal and regulatory breaches<\/td><td>Zero-tolerance enforcement with enhanced penalties<\/td><\/tr><tr><td><strong>Risk Elimination<\/strong><\/td><td>Pharmaceutical sales and procurement vulnerabilities<\/td><td>Systematic review of pricing, tendering, and distribution channels<\/td><\/tr><tr><td><strong>Service Standardization<\/strong><\/td><td>Healthcare delivery quality<\/td><td>Updated protocols and performance metrics<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-sector-impact-amp-compliance-requirements\" class=\"wp-block-heading\">Sector Impact &amp; Compliance Requirements<\/h2>\n\n\n\n<h3 id=\"h-pharmaceutical-industry-implications\" class=\"wp-block-heading\">Pharmaceutical Industry Implications<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Sales Practices<\/strong>: Enhanced scrutiny of promotional activities, speaker fees, and hospitality expenses<\/li>\n\n\n\n<li><strong>Procurement Processes<\/strong>: Transparent tendering procedures with mandatory disclosure requirements<\/li>\n\n\n\n<li><strong>Pricing Transparency<\/strong>: Stricter controls on drug pricing and rebate structures<\/li>\n\n\n\n<li><strong>Distribution Channels<\/strong>: Comprehensive audit trails for product movement from manufacturer to end-user<\/li>\n\n\n\n<li><strong>Compliance Infrastructure<\/strong>: Requirement for robust internal compliance departments and whistleblower mechanisms<\/li>\n<\/ul>\n\n\n\n<h3 id=\"h-healthcare-provider-requirements\" class=\"wp-block-heading\">Healthcare Provider Requirements<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Prescription Practices<\/strong>: Monitoring of prescribing patterns and potential conflicts of interest<\/li>\n\n\n\n<li><strong>Procurement Oversight<\/strong>: Independent review committees for medical device and pharmaceutical purchases<\/li>\n\n\n\n<li><strong>Financial Disclosures<\/strong>: Mandatory reporting of relationships with pharmaceutical and medical device companies<\/li>\n\n\n\n<li><strong>Service Quality<\/strong>: Standardized clinical pathways and outcome measurement frameworks<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-market-context-amp-historical-precedent\" class=\"wp-block-heading\">Market Context &amp; Historical Precedent<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Ongoing Anti-Corruption Drive<\/strong>: Part of China&#8217;s broader healthcare reform initiative launched in 2023<\/li>\n\n\n\n<li><strong>Previous Enforcement Actions<\/strong>: Over 200 pharmaceutical executives investigated since 2024, including senior executives from multinational corporations<\/li>\n\n\n\n<li><strong>Economic Impact<\/strong>: Estimated $2-3 billion in industry restructuring costs as companies adapt to stricter compliance requirements<\/li>\n\n\n\n<li><strong>Investor Sentiment<\/strong>: Short-term market volatility expected as companies assess compliance exposure and operational adjustments<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-strategic-implications-for-stakeholders\" class=\"wp-block-heading\">Strategic Implications for Stakeholders<\/h2>\n\n\n\n<h3 id=\"h-multinational-pharmaceutical-companies\" class=\"wp-block-heading\">Multinational Pharmaceutical Companies<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Compliance Investment<\/strong>: Significant resources required for enhanced monitoring and reporting systems<\/li>\n\n\n\n<li><strong>Business Model Adaptation<\/strong>: Shift from relationship-based to value-based selling approaches<\/li>\n\n\n\n<li><strong>Partnership Strategy<\/strong>: Increased reliance on local partners with established compliance track records<\/li>\n<\/ul>\n\n\n\n<h3 id=\"h-domestic-chinese-companies\" class=\"wp-block-heading\">Domestic Chinese Companies<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Competitive Advantage<\/strong>: Potential market share gains for companies with robust compliance infrastructure<\/li>\n\n\n\n<li><strong>Operational Efficiency<\/strong>: Streamlined processes through standardized procurement and sales protocols<\/li>\n\n\n\n<li><strong>International Expansion<\/strong>: Enhanced credibility for global market entry through demonstrated compliance maturity<\/li>\n<\/ul>\n\n\n\n<h3 id=\"h-healthcare-institutions\" class=\"wp-block-heading\">Healthcare Institutions<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Governance Enhancement<\/strong>: Strengthened board oversight of procurement and vendor relationships<\/li>\n\n\n\n<li><strong>Cost Management<\/strong>: Potential reduction in drug and device costs through transparent pricing mechanisms<\/li>\n\n\n\n<li><strong>Quality Improvement<\/strong>: Focus on clinical outcomes rather than commercial considerations<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">This regulatory initiative represents the most comprehensive anti-corruption framework in China&#8217;s healthcare sector to date, signaling the government&#8217;s commitment to sustainable healthcare system reform and international best practices in pharmaceutical governance.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward-Looking Statements<\/strong><br>This brief contains forward-looking statements regarding regulatory implementation, market impacts, and compliance requirements. Actual outcomes may differ due to evolving regulatory interpretations, enforcement priorities, and industry adaptation timelines.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>China&#8217;s National Health Commission (NHC) released the &#8220;Notice on Key Points for Rectifying Misconduct in&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[4],"tags":[60],"class_list":["post-67891","post","type-post","status-publish","format-standard","hentry","category-policy-regulatory","tag-nhc-nhfpc"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.7) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>China&#039;s National Health Commission Launches Anti-Corruption Campaign Targeting Pharmaceutical Sales and Healthcare Services Misconduct - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China&#039;s National Health Commission (NHC) released the &quot;Notice on Key Points for Rectifying Misconduct in Pharmaceutical Sales, Procurement, and Healthcare Services&quot; this week, marking a significant escalation in the government&#039;s ongoing anti-corruption efforts within the healthcare sector.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=67891\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"China&#039;s National Health Commission Launches Anti-Corruption Campaign Targeting Pharmaceutical Sales and Healthcare Services Misconduct\" \/>\n<meta property=\"og:description\" content=\"China&#039;s National Health Commission (NHC) released the &quot;Notice on Key Points for Rectifying Misconduct in Pharmaceutical Sales, Procurement, and Healthcare Services&quot; this week, marking a significant escalation in the government&#039;s ongoing anti-corruption efforts within the healthcare sector.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=67891\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-10T06:54:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67891#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67891\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"China&#8217;s National Health Commission Launches Anti-Corruption Campaign Targeting Pharmaceutical Sales and Healthcare Services Misconduct\",\"datePublished\":\"2026-06-10T06:54:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67891\"},\"wordCount\":513,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"NHC (NHFPC)\"],\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=67891#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67891\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=67891\",\"name\":\"China's National Health Commission Launches Anti-Corruption Campaign Targeting Pharmaceutical Sales and Healthcare Services Misconduct - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-06-10T06:54:48+00:00\",\"description\":\"China's National Health Commission (NHC) released the \\\"Notice on Key Points for Rectifying Misconduct in Pharmaceutical Sales, Procurement, and Healthcare Services\\\" this week, marking a significant escalation in the government's ongoing anti-corruption efforts within the healthcare sector.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67891#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=67891\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67891#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"China&#8217;s National Health Commission Launches Anti-Corruption Campaign Targeting Pharmaceutical Sales and Healthcare Services Misconduct\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"China's National Health Commission Launches Anti-Corruption Campaign Targeting Pharmaceutical Sales and Healthcare Services Misconduct - Insight, China&#039;s Pharmaceutical Industry","description":"China's National Health Commission (NHC) released the \"Notice on Key Points for Rectifying Misconduct in Pharmaceutical Sales, Procurement, and Healthcare Services\" this week, marking a significant escalation in the government's ongoing anti-corruption efforts within the healthcare sector.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=67891","og_locale":"en_US","og_type":"article","og_title":"China's National Health Commission Launches Anti-Corruption Campaign Targeting Pharmaceutical Sales and Healthcare Services Misconduct","og_description":"China's National Health Commission (NHC) released the \"Notice on Key Points for Rectifying Misconduct in Pharmaceutical Sales, Procurement, and Healthcare Services\" this week, marking a significant escalation in the government's ongoing anti-corruption efforts within the healthcare sector.","og_url":"https:\/\/flcube.com\/?p=67891","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-06-10T06:54:48+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=67891#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=67891"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"China&#8217;s National Health Commission Launches Anti-Corruption Campaign Targeting Pharmaceutical Sales and Healthcare Services Misconduct","datePublished":"2026-06-10T06:54:48+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=67891"},"wordCount":513,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["NHC (NHFPC)"],"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=67891#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=67891","url":"https:\/\/flcube.com\/?p=67891","name":"China's National Health Commission Launches Anti-Corruption Campaign Targeting Pharmaceutical Sales and Healthcare Services Misconduct - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-06-10T06:54:48+00:00","description":"China's National Health Commission (NHC) released the \"Notice on Key Points for Rectifying Misconduct in Pharmaceutical Sales, Procurement, and Healthcare Services\" this week, marking a significant escalation in the government's ongoing anti-corruption efforts within the healthcare sector.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=67891#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=67891"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=67891#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"China&#8217;s National Health Commission Launches Anti-Corruption Campaign Targeting Pharmaceutical Sales and Healthcare Services Misconduct"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/67891","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=67891"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/67891\/revisions"}],"predecessor-version":[{"id":67892,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/67891\/revisions\/67892"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=67891"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=67891"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=67891"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}